Truist Financial’s Compugen CGEN Stock Holding History

Truist Financial’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,000	Closed	-$60K	–	2751
2021 Q3	$60K	Hold	10,000	–	–	﹤0.01%	2660
2021 Q2	$83K	Buy	+10,000	New	+$81.2K	﹤0.01%	2658

Other funds holding CGEN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Truist Financial's CGEN Position: Q4 2021 in Review

Truist Financial sold out of Compugen (CGEN) in Q4 2021, closing a stake of 10,000 shares — an estimated $60K sold.

Truist Financial first reported a position in CGEN in Q2 2021 and held it in 2 quarters. The position peaked at $83K in Q2 2021. 114 funds tracked by Wall St. Rank hold CGEN as of Q4 2021.

Truist Financial reported no remaining Compugen position as of Q4 2021 after selling out during the quarter.
Truist Financial sold 10,000 Compugen shares in Q4 2021, an estimated $60K.
Truist Financial first reported a position in Compugen in Q2 2021 and held it in 2 quarters.
Truist Financial's Compugen position peaked at $83K in Q2 2021.
114 funds tracked by Wall St. Rank held Compugen as of Q4 2021.

Based on Truist Financial's 13F filing for Q4 2021, filed 14 Feb 2022.